4.6 Article

Spontaneous Intracerebral and Intraventricular Hemorrhage: Advances in Minimally Invasive Surgery and Thrombolytic Evacuation, and Lessons Learned in Recent Trials

Journal

NEUROSURGERY
Volume 74, Issue -, Pages S142-S150

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1227/NEU.0000000000000221

Keywords

Intracerebral hemorrhage; Intracranial hemorrhage; Intraventricular hemorrhage; Minimally invasive surgery; Thrombolysis

Ask authors/readers for more resources

Optimal management of spontaneous intracerebral hemorrhage (ICH) remains one of the highly debated areas in the field of neurosurgery. Earlier studies comparing open surgical intervention with best medical management failed to show a clear benefit. More recent experience with minimally invasive techniques has shown greater promise. Well-designed phase II trials have confirmed the safety and preliminary treatment effect of thrombolytic aspiration and clearance of spontaneous ICH and associated intraventricular obstructive hemorrhage. Those trials are reviewed, including respective protocols and technical nuances, and lessons learned regarding patient selection, the concept of hemorrhage stabilization, optimization of the surgical procedure, and thrombolytic dosing decisions. These concepts have been incorporated in the design of ongoing definite phase III randomized trials (MISTIE and CLEAR) funded by the National Institutes of Health. These are presented including the role of surgical leadership in the training and monitoring of the surgical task and quality assurance. The impact of these techniques on neurosurgical practice is discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies

Gina Li, Nicolas Bonamici, Mahua Dey, Maciej S. Lesniak, Irina V. Balyasnikova

EXPERT OPINION ON DRUG DELIVERY (2018)

Review Clinical Neurology

A Survey of the Neuro-Oncology Landscape

Rimas V. Lukas, Jing Wu, Mahua Dey, Robin A. Buerki, Richard W. Byrne, George J. Dohrmann

JOURNAL OF CLINICAL NEUROLOGY (2018)

Article Oncology

Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas

Anna Filley, Mario Henriquez, Tanmoy Bhowmik, Brij Nath Tewari, Xi Rao, Jun Wan, Margaret A. Miller, Yunlong Liu, R. Timothy Bentley, Mahua Dey

JOURNAL OF NEURO-ONCOLOGY (2018)

Review Immunology

Plasmacytoid dendritic cell in immunity and cancer

Dana Mitchell, Sreenivasulu Chintala, Mahua Dey

JOURNAL OF NEUROIMMUNOLOGY (2018)

Article Oncology

Efficacy of pre-operative stereotactic radiosurgery followed by surgical resection and correlative radiobiological analysis for patients with 1-4 brain metastases: study protocol for a phase II trial

Wei X. Huff, Namita Agrawal, Scott Shapiro, James Miller, Charles Kulwin, Mitesh Shah, Jesse J. Savage, Troy Payner, Alexander Vortmeyer, Gordon Watson, Mahua Dey

RADIATION ONCOLOGY (2018)

Article Cell Biology

Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma

Tanwir Hasan, Seamus P. Caragher, Jack M. Shireman, Cheol H. Park, Fatemeh Atashi, Shivani Baisiwala, Gina Lee, Donna Guo, Jennifer Y. Wang, Mahua Dey, Meijing Wu, Maciej S. Lesniak, Craig M. Horbinski, C. David James, Atique U. Ahmed

CELL DEATH & DISEASE (2019)

Review Biochemistry & Molecular Biology

The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology

Wei X. Huff, Jae Hyun Kwon, Mario Henriquez, Kaleigh Fetcko, Mahua Dey

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Common Molecular Alterations in Canine Oligodendroglioma and Human Malignant Gliomas and Potential Novel Therapeutic Targets

Dana Mitchell, Sreenivasulu Chintala, Kaleigh Fetcko, Mario Henriquez, Brij N. Tewari, Atique Ahmed, R. Timothy Bentley, Mahua Dey

FRONTIERS IN ONCOLOGY (2019)

Article Biochemical Research Methods

Intraoperative detection of isocitrate dehydrogenase mutations in human gliomas using a miniature mass spectrometer

Hannah Marie Brown, Fan Pu, Mahua Dey, James Miller, Mitesh V. Shah, Scott A. Shapiro, Zheng Ouyang, Aaron A. Cohen-Gadol, R. Graham Cooks

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)

Article Neurosciences

Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis

Teresa P. Easwaran, Nicola Lancki, Mario Henriquez, Alexander O. Vortmeyer, Nicholas M. Barbaro, Denise M. Scholtens, Atique U. Ahmed, Mahua Dey

Summary: This study investigated the association between molecular classification of gliomas and seizure presentation as well as post-operative seizure control. It found that the presence of IDH mutation is associated with seizures at presentation, while IDH-mutant tumors are associated with worse post-operative seizure outcomes.

NEUROMOLECULAR MEDICINE (2021)

Review Clinical Neurology

Brain metastases: An update on the multi-disciplinary approach of clinical management

D. K. Mitchell, H. J. Kwon, P. A. Kubica, W. X. Huff, R. O'Regan, M. Dey

Summary: Brain metastasis is the most common malignant intracranial neoplasm in adults, with an increasing incidence due to improved surveillance, effective systemic therapy, and an aging population. Timely and accurate diagnosis is crucial for improving long-term outcomes. Treatment approaches should be based on the type and molecular profile of the primary tumor, as well as the size, number, and location of metastatic lesions.

NEUROCHIRURGIE (2022)

Review Health Care Sciences & Services

Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials

Sudarshawn Damodharan, Montserrat Lara-Velazquez, Brooke Carmen Williamsen, Jeffrey Helgager, Mahua Dey

Summary: Diffuse intrinsic pontine glioma (DIPG) is a type of brainstem tumor that occurs primarily in children and is characterized by high infiltrative capacity and multiple genetic mutations. Advances in molecular understanding, including the categorization of tumors with the H3 K27M mutation and the development of treatment options, have improved our knowledge of this disease.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Cell Biology

GM-CSF and IL-7 fusion cytokine engineered tumor vaccine generates long-term Th-17 memory cells and increases overall survival in aged syngeneic mouse models of glioblastoma

Jack M. Shireman, Nikita Gonugunta, Lei Zhao, Akshita Pattnaik, Emily Distler, Skyler Her, Xiaohu Wang, Rahul Das, Jaques Galipeau, Mahua Dey

Summary: Age-related immune dysfunctions have close connections with pathologies like cancers and lack of vaccine efficacy among the elderly. An engineered fusokine, GIFT-7, has the potential to reverse aging-related lymphoid organ atrophy. In experiments using aged mouse models of glioblastoma, peripheral vaccination with GIFT-7TVax resulted in thymic regeneration, long-term antitumor immunity, increased pro-inflammatory cytokines, enhanced T-cell trafficking to the brain, and robust T-cell formation.

AGING CELL (2023)

Review Oncology

Sexual dimorphism of the immune system predicts clinical outcomes in glioblastoma immunotherapy: A systematic review and meta-analysis

Jack M. Shireman, Simon Ammanuel, Jens C. Eickhoff, Mahua Dey

Summary: This study reveals significant differences in immunobiology between males and females, which also affect the overall response to immunotherapy in GBM treatment.

NEURO-ONCOLOGY ADVANCES (2022)

Article Psychology, Multidisciplinary

The Effect of Pet Therapy and Artist Interactions on Quality of Life in Brain Tumor Patients: A Cross-Section of Art and Medicine in Dialog

Stefan Petranek, Jennifer Pencek, Mahua Dey

BEHAVIORAL SCIENCES (2018)

No Data Available